Endexx Corporation (OTC: EDXC) Surges On Amazon (NASDAQ: AMZN), Tar-get (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS) Hyla Non-Nicotine Vaping In US Plus International Expansion; EDXC Positioning Bodes Well In Possible Vaping Market Shakeup
Endexx Corporation (OTC: EDXC) Endexx Corporation (OTC: EDXC) surges On Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS) sales of Hyla brand Guarana-plant based Non-Nicotine Vaping In US plus International Expansion. EDXC positioning bodes well in new possible vaping market shakeup as major player Altria now cuts cord from nicotine-based vaping/e-cigarette brand in which it had invested $12.8 billion. Altria has ended its non-compete with that brand and is newly free to acquire or joint venture with a ‘next generation’ vaping/e-cigarette company, according to a new report in the Wall Street Journal.
StockMarketPress is a media company which is spotlighting the cannabis industry analyzing how growth in cannabis legalization by state in 2022 could impact companies and investors. Some of the stocks it recently reported on include Endexx Corporation (OTC: EDXC) Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF), The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), OrganiGram Holdings Inc. (NASDAQ: OGI), Canopy Growth Corp. (NASDAQ: CGC) CBD Unlimited, Inc. (OTC PINK: EDXC).
EDXC believes its acquisition of controlling interest in Hyla will expand its international distribution and mean a “significant increase in the company’s consolidated revenue, according to Todd Davis, EDXC CEO and Chairman. Nick Mehdi, Hyla CEO, commented, “With more than 1,000 stores carrying the (Hyla vaping product) in the U.S., and the potential to expand our market penetration to as many as 19 countries by the end of 2022, we are excited to add our product line to the already strong retail presence Endexx maintains.”
The possible shakeup in the vaping/e-cigarette market by Altria’s move to cut cords with the brand it had invested nearly $13 billion into in 2018 bodes well for EDXC’s positioning as a US and international growth leader in non-nicotine vaping. Endexx further states that its majority controlled subsidiary Hyla’s proprietary device produces an unprecedented number of 4,500 puffs per device. Its initial inventory of 140,000 devices were sold out within the initial months of its availability, Endexx says. It also says the device is CE approved and has UL global safety certification.
The new countries where Hyla’s vaping marketing approvals have been initiated include: Germany, Italy, Israel, Egypt, Slovenia, Romania, Iran and Bahrain. These eight new country markets if approved will be added to Hyla’s currently active markets including the US, Canada, Czech Republic, Georgia, Russia, Slovakia, South Africa, Switzerland, United Arab Emirates, the U.K., and Uzbekistan, the company says.
In addition to the Hyla brand of non-nicotine vaping, EDXC also markets a complete line of skincare products including balms, creams, lotions, butters, masks, scrubs and oils. The goal is healthy skin and grooming wellness. Formulations have ingredients designed for optimal absorption and support of skin health.
This dovetails with the Company’s acquisition and marketing of safe, non-nicotine plant based vaping utilizing the Guarana plant.
For additional information on the Hyla brand non-nicotine plant-based vaping acquisition, please see Endexx’s recent Form 8-K filing.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Stock Market Press
110 Wall St.
New York, NY 10005 email@example.com https://twitter.com/PressStock
Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press